Key Highlights

  • Medibank's fully franked FY26 dividends totalled 19.2 cents per share, up 6.7%.
  • The Payout Ratio was 83.0% of underlying net profit.
  • The 10.9 cent final Dividend was paid on 8 October 2026.
  • The AGM on 18 November and the April 2027 premium outcome are the next points to monitor.

Medibank Private Limited (ASX:MPL) is a healthcare-linked name in discussions of the best dividend stocks on the ASX, with fully franked FY26 dividends of 19.2 cents per share, up 6.7%. That total comprises an Interim Dividend of 8.3 cents and a final dividend of 10.9 cents, and it represents an 83.0% payout of underlying net profit after tax. The final dividend's ex-dividend date was 2 September 2026, its Record Date was 3 September and it was paid on 8 October. This article is factual and does not make a recommendation.

Dividend Details

The final dividend of 10.9 cents per share cost about $300.2 million, and the full-year total cost about $528.8 million. Both were fully franked, which provides eligible Australian shareholders with credits for company tax already paid. The interim dividend had a record date of 27 February 2026 and was paid on 18 March 2026, showing the company's usual half-yearly pattern.

An 83.0% payout ratio means that most of Underlying Profit was returned to shareholders in dividends. A high payout can be sustained when a Business has steady cash generation and limited Capital needs, but it leaves less for reinvestment. Medibank's capital position gives it additional flexibility, with a required capital ratio for Health Insurance of 13.3%, above its target range.

Earnings Foundation

Underlying net profit after tax rose 2.9% to $636.8 million in FY26, and group Revenue from external customers rose 5.9% to $9,115.2 million. Group operating profit increased 6.7% to $813.5 million, while Medibank Health segment profit rose 31.3% to $100.7 million. Operating expenses grew 7.1%, and productivity savings of $10 million were achieved.

Private health insurance has characteristics that may appeal to income-focused investors, including regular premium income and a regulated framework. Demand, however, depends on affordability and policyholder behaviour. Net resident policyholders rose by 22,100, while non-resident policy units fell 2.3%, showing some variation across segments. The ability to keep adding customers will influence future earnings.

FY27 Outlook for Income Investors

Medibank expects FY27 resident health insurance gross Margin to be broadly consistent with FY26, subject to the outcome of the 1 April 2027 premium increase. Its outlook includes growth in non-resident gross profit, supported by a stabilising student portfolio and new products, and Medibank Health segment profit growth of around 25%, including a full year of Better Medical.

Expense growth is expected from inflation, Volume and Investment in AI, partly offset by about $10 million in productivity savings. Cybercrime costs are expected to be under $20 million, excluding the outcome of regulatory investigations or litigation. Any large legal or regulatory outcome could affect available capital and, potentially, the board's decisions on future dividends, although the company has not indicated this.

How Rising Rates Affect Medibank

Higher interest rates can provide a direct benefit to health insurers holding investment portfolios. Medibank estimates about $6.4 million in additional annual interest income for each 25 basis point change in the cash rate. With the Reserve Bank's latest rise to 4.85%, this tailwind has increased. It is modest compared with underlying profit of $636.8 million, but it provides a useful offset as other costs increase.

Higher rates and Inflation also weigh on household budgets, and private health insurance is a discretionary spend for many households. Some customers may reduce cover or look for cheaper products. The ABS reported 4.3% annual inflation in September, and the Reserve Bank expects consumption to remain under pressure. The net effect on Medibank will depend on policyholder numbers and the premium round.

Comparison With Other Income Options

Fully franked dividends are common among Australian insurers and banks, but payout ratios and growth rates differ. Medibank's 83.0% payout compares with Westpac's 75% excluding notable items and BHP's 66%. Each company has a different Capital Structure and regulatory regime, so a higher ratio does not automatically indicate more risk or a better income prospect.

Dividend growth of 6.7% exceeded underlying profit growth of 2.9% in FY26, which is not sustainable indefinitely if it continues at that pace unless Earnings accelerate or the payout ratio moves further upward. The company's target range for payouts and the board's decisions in future periods will provide further guidance. Shareholders can raise questions at the Annual General Meeting on 18 November 2026.

Regulatory and Policy Factors

The federal government approves annual premium changes for private health insurers. Decisions on the April 2027 increase will be significant, since Medibank has explicitly linked its margin outlook to that outcome. Government policy on the private health insurance rebate, as well as changes in hospital contracting and medical costs, also influence results across the industry.

Capital standards from APRA also apply. Medibank's ratio above target provides a buffer, and the company has flagged capacity for further Merger and Acquisition activity. Investment in acquisitions would compete with potential capital returns. The balance between these Options is a question shareholders may want to explore at the annual meeting, along with the outlook for Medibank Health.

Dividend reinvestment and capital management settings are set out in Medibank's announcements, and the AGM provides an opportunity to raise questions directly. With the group's capital ratio above target, shareholders may be interested in the board's priorities between higher dividends, acquisitions and retained capital.

Any change in franking capacity is unlikely in the near term, but it would be disclosed in dividend notices published to the market by the company.

Key Takeaways

Medibank's fully franked FY26 dividends totalled 19.2 cents per share, up 6.7%, with an 83.0% payout of underlying net profit. The 10.9 cent final dividend was paid on 8 October 2026. FY27 outlook points to steady resident margins and growth at Medibank Health. The AGM on 18 November and the April 2027 premium outcome are the next points to monitor.